Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1977-04-20
1978-07-25
Rosen, Sam
Drug, bio-affecting and body treating compositions
Lymphokine
195 15, A61K 3912, C12K 700
Patent
active
041029968
ABSTRACT:
HB.sub.c Ag is prepared by isolating Dane particles by isopycnic banding of fluid from HB.sub.s Ag positive donors, optionally but preferably pelleting the Dane particles, and then removing the surface antigen by contacting the Dane particles with a nonionic surfactant having from about 15 to about 35 oxyethylene units in the presence of a reducing agent such as mercaptoethanol. The isolated core antigen is used as a diagnostic and immunologic agent.
REFERENCES:
ling et al., Hepatitis Scientific Memoranda, Jan. 1976, Memo H.
Almeida et al., The Lancet, Dec. 4, 1971, pp. 1225-1227.
Barker et al., J. of Virology, Dec. 1974, pp. 1552-1558.
Fauvel et al., Can. J. Microbiol., vol. 21, (1975), pp. 905-910.
Greenman et al., Vox Sanguinis, vol. 29, (1975), pp. 77-80.
Kaplan et al., J. Virology, vol. 12, No. 5, (1973), pp. 995-1005.
Moritsugu et al., J. of Immunol., vol. 114, Jun. 1975, pp. 1792-1798.
Tsuda et al., J. of Immunol., vol. 115, Sep. 1975, pp. 834-838.
McAleer William J.
Miller William J.
Wasmuth Edward H.
Merck & Co. , Inc.
Perrella Donald J.
Rosen Sam
LandOfFree
Method of preparing hepatitis B core antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing hepatitis B core antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing hepatitis B core antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1421733